Lionel Berthoux 
   Accueil Main page Communications Communications

Accueil
Main page
Formation académique
Academical background
Enseignement
Teaching
Champs d'expertise
Research interests
Projets de recherche
Research program
Publications
Publications
Communications
Communications
Anciens membres
Former lab members

Dernière mise à jour
2019-03-16
Communications
Communications

  Présentations par L. Berthoux depuis 2010 / L. Berthoux's presentations since 2010

  1. Dufour, N. Joubarne, C. Claudel, N. Merindol, M.B. Plourde, L. Berthoux. 2016. CRISPR-Cas9-mediated editing of the innate effector TRIM5α gene to confer resistance to HIV-1. 12th Meeting of the Quebec Association of Gene Therapy, Montreal, Canada.
  2. Masroori, N. Mérindol, L. Berthoux. 2016. Is PML (TRIM19) a regulator or an effector in the antiviral response? 35th annual meeting of the American Society for Virology, Blackburn, VA, USA.
  3. Berthoux, U. Jung, K. Urak, M. Veillette, Q.T. Pham, M.-E. Nepveu-Traversy, J.J. Rossi. 2015. The innate immune effector TRIM5alpha as a candidate for gene-based strategies against HIV-1. 34th annual meeting of the American Society for Virology, London, Canada.
  4. Pawlica, N. Masroori, V. Le Sage, A.J. Mouland, L. Berthoux. 2014. TRIM5α Cellular Partners for the Restriction of Incoming Lentiviruses and the Activation of Innate Immune Responses. International Union of Microbiological Societies, Montreal, Canada.
  5. -É. Nepveu-Traversy and L. Berthoux. TRIM5α determinants for the activation of innate immunity. 2014. 21st Conference on Retroviruses and Opportunistic Infections, Boston, USA.
  6. -É. Nepveu-Traversy, N. Masroori, P. Pawlica, R. Gorelick, A.J. Mouland, L. Berthoux. Cellular co-factors involved in the restriction of retroviruses by proteins of the TRIM5 family. 2013. 9th retroviral nucleocapsid and assembly meeting, Montreal, Canada.
  7. Veillette, Q.T. Pham, A. Brandariz-Nunez, V. B. Shah, C. Thibert-Lefebvre, N. Chandonnet, C. R. Aiken, F. Diaz-Griffero, L. Berthoux. Mechanism of HIV-1 Resistance to Human TRIM5alpha Mutants. 2012. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, USA.
  8. T. Pham, L. Berthoux: Mutagenic screen-based selection of TRIM5α(hu) mutants that potently restrict HIV-1. 2010. Cold Spring Harbor meeting on retroviruses.
  9. -É. Nepveu-Traversy, L. Berthoux: A possible role for sumoylation in TRIM5 proteins-mediated inhibition of retroviruses. 2010. 5th International conference on SUMO, Ubiquitin and UBL proteins, Houston, TX.

   Sélection de présentations par les membres du laboratoire depuis 2010:

   Selected lab members' presentations since 2010:

  1. Merindol, M. El-Far, M. Sylla, N. Masroori, C. Dufour, J-x Li, C. Tremblay, L. Berthoux. 2017. Endogenous TRIM5alpha senses HIV-1 in elite controllers and triggers an antiviral state in infected cells. Cold Spring Harbor meeting on retroviruses, NY, USA.
  2. Merindol, M. El-Far, M. Sylla, N. Masroori, J-x Li, C. Dufour, C. Tremblay, L. Berthoux. 2017. Endogenous TRIM5alpha senses HIV-1 in elite controllers. 26th Annual Canadian Conference on HIV/AIDS Research, Montreal, Canada.
  3. Masroori, P. Cherry, N. Merindol, J-x. Li, L. Poulain, M.B. Plourde, L. Berthoux. 2017. PML/TRIM19 contributes to the antiviral state against HIV-1 in a cellular context-dependent manner. 26th Annual Canadian Conference on HIV/AIDS Research, Montreal, Canada.
  4. Masroori, L. Berthoux. PML, a potential restriction factor against lentiviruses. 2014. Canadian Conference on HIV/AIDS Research, St-John’s, Canada.
  5. Pawlica, A.J. Mouland, L. Berthoux. Involvement of microtubules and dynein complexes in HIV-1 core disassembly and in its restriction by TRIM5α. 2013. 9th retroviral nucleocapsid and assembly meeting, Montreal, Canada.
  6. Pawlica, L. Berthoux: Retroviral restriction mediated by TRIM5α protein is decreased by disrupting integrity of microtubules and dynein complex. 2012. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA.
  7. Pawlica, M. Malbec, L. Berthoux: Identification and characterization of cellular factors involved in TRIM5alpha-mediated restriction. 2011. Cold Spring Harbor meeting on retroviruses, NY, USA.
  8. -É. Nepveu-Traversy, L. Berthoux: A mutation affecting TRIM5alpha stability, self-ubiquitylation and restriction levels. 2011. Cold Spring Harbor meeting on retroviruses, NY, USA.
  9. Veillette, Q. T. Pham, M. B. Plourde, L. Berthoux: HIV-1 resistance to restriction by human TRIM5α mutants. 2011. Cold Spring Harbor meeting on retroviruses, NY, USA.
  10. T. Pham, A. Bouchard, L. Berthoux: Generation of human TRIM5α mutants with anti-HIV-1 activity. 2010. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA.
  11. -É. Nepveu-Traversy, L. Berthoux: A role for sumoylation in TRIM5 protein-mediated restriction? 2010. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA.